• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Pharmacist-Led Strategies for Adverse Event Management in mCRC

Opinion
Video

Experts discuss how pharmacists contribute to managing adverse events and toxicity for patients undergoing metastatic colorectal cancer (mCRC) treatment. They explore the factors influencing patient adherence to third-line therapies and ways pharmacists can improve patient education to enhance adherence to treatment regimens.

Video content above is prompted by the following:

  • In what ways do pharmacists contribute to managing adverse events and toxicity for patients undergoing mCRC treatment?
  • What factors influence patient adherence to third-line therapies for mCRC, and how can pharmacists improve patient education to address these challenges and ensure better adherence to treatment regimens?

Related Videos
3 experts are featured in this series.
5 experts are featured in this series
4 experts are featured in this series.
4 experts are featured in this series.
5 experts are featured in this series
1 expert is featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences
AJMC®
All rights reserved.